Netenax (Netilmicin)

Netilmicin, the active ingredient in Netenax, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It is employed to treat bacterial infections of the eye, such as conjunctivitis, in adult and pediatric patients where appropriate. The drug works by targeting bacterial protein synthesis, leading to rapid bacterial clearance and symptom relief.

GNH USA supplies Netenax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to global markets.

Netenax is indicated for bacterial ocular infections, targeting the pathogens that cause conjunctivitis and related conditions. - Bacterial conjunctivitis: reduces bacterial load and alleviates redness, discharge and irritation. - Bacterial keratitis: eradicates causative organisms and supports corneal healing. - Post‑operative ocular infection: prevents bacterial contamination after eye surgery.

Adverse ocular reactions may occur with Netenax use.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Excessive tearing. - Blurred vision. - Foreign body sensation. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic reactions including anaphylaxis. - Severe ocular inflammation or ulceration. - Vision loss. - Systemic nephrotoxicity (rare with ocular use). - Corneal edema.

Use Netenax only under professional supervision and consider the following precautions. - Allergy assessment: avoid if known hypersensitivity to aminoglycosides. - Contact lens wearers: discontinue lens use during treatment. - Pregnancy: prescribe only when benefits outweigh potential risks. - Renal impairment: monitor for systemic absorption in severe cases. - Store at room temperature: keep in the original container, protect from light and moisture.

Netenax may interact with other medications; review the following.

Major Interactions (Avoid): - Nephrotoxic drugs (e.g., gentamicin, vancomycin): increased risk of kidney injury. - Loop diuretics (e.g., furosemide): may potentiate nephrotoxicity. - Neuromuscular blocking agents: possible enhanced muscle weakness.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of infection. - Non‑steroidal anti‑inflammatory eye drops: potential additive ocular irritation.